Trends in Antiparkinsonian Medication Use in New Zealand: 1995–2011

Table 1

Defined daily dose amounts for antiparkinsonian agents available in New Zealand.

Antiparkinsonian agent	Defined daily dose (mg)
Levodopa with decarboxylase inhibitor	600
COMTIs
Tolcapone	450
Entacapone	1000
Amantadine	200
Dopamine agonists
Ropinirole	6
Apomorphine	20
Pergolide	3
Lisuride	0.6
Bromocriptine	40
MAOIs
Selegiline	5
Anticholinergics
Benztropine	2
Orphenadrine	200
Procyclidine	25

MAOIs: monoamine oxidase inhibitors; COMTIs: catechol-o-methyl transferase inhibitors.